本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

20.48
+1.045.32%
成交量:63.17萬
成交額:1,270.85萬
市值:25.73億
市盈率:-11.40
高:20.55
開:19.58
低:19.25
收:19.44
資料載入中...
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities